BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 25706627)

  • 1. Stromal contribution to the colorectal cancer transcriptome.
    Isella C; Terrasi A; Bellomo SE; Petti C; Galatola G; Muratore A; Mellano A; Senetta R; Cassenti A; Sonetto C; Inghirami G; Trusolino L; Fekete Z; De Ridder M; Cassoni P; Storme G; Bertotti A; Medico E
    Nat Genet; 2015 Apr; 47(4):312-9. PubMed ID: 25706627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional mimicry by tumor-associated stroma.
    Kim H; Verhaak RG
    Nat Genet; 2015 Apr; 47(4):307-9. PubMed ID: 25814306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
    McCorry AM; Loughrey MB; Longley DB; Lawler M; Dunne PD
    J Pathol; 2018 Dec; 246(4):422-426. PubMed ID: 30105762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.
    Calon A; Lonardo E; Berenguer-Llergo A; Espinet E; Hernando-Momblona X; Iglesias M; Sevillano M; Palomo-Ponce S; Tauriello DV; Byrom D; Cortina C; Morral C; Barceló C; Tosi S; Riera A; Attolini CS; Rossell D; Sancho E; Batlle E
    Nat Genet; 2015 Apr; 47(4):320-9. PubMed ID: 25706628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer.
    Torres S; Bartolomé RA; Mendes M; Barderas R; Fernandez-Aceñero MJ; Peláez-García A; Peña C; Lopez-Lucendo M; Villar-Vázquez R; de Herreros AG; Bonilla F; Casal JI
    Clin Cancer Res; 2013 Nov; 19(21):6006-19. PubMed ID: 24025712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
    Isella C; Brundu F; Bellomo SE; Galimi F; Zanella E; Porporato R; Petti C; Fiori A; Orzan F; Senetta R; Boccaccio C; Ficarra E; Marchionni L; Trusolino L; Medico E; Bertotti A
    Nat Commun; 2017 May; 8():15107. PubMed ID: 28561063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
    Kramer N; Schmöllerl J; Unger C; Nivarthi H; Rudisch A; Unterleuthner D; Scherzer M; Riedl A; Artaker M; Crncec I; Lenhardt D; Schwarz T; Prieler B; Han X; Hengstschläger M; Schüler J; Eferl R; Moriggl R; Sommergruber W; Dolznig H
    Oncogene; 2017 Sep; 36(39):5460-5472. PubMed ID: 28553956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
    Unger C; Kramer N; Unterleuthner D; Scherzer M; Burian A; Rudisch A; Stadler M; Schlederer M; Lenhardt D; Riedl A; Walter S; Wernitznig A; Kenner L; Hengstschläger M; Schüler J; Sommergruber W; Dolznig H
    Oncogene; 2017 Sep; 36(38):5341-5355. PubMed ID: 28534511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
    Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
    Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
    Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
    Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts are not formed from cancer cells by epithelial-to-mesenchymal transition in nu/nu mice.
    Dvořánková B; Smetana K; Říhová B; Kučera J; Mateu R; Szabo P
    Histochem Cell Biol; 2015 May; 143(5):463-9. PubMed ID: 25387587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
    Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
    Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between stromal fibroblasts and colorectal cancer cells in the expression of vascular endothelial growth factor.
    Koshida Y; Kuranami M; Watanabe M
    J Surg Res; 2006 Aug; 134(2):270-7. PubMed ID: 16600304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasis.
    Berdiel-Acer M; Cuadras D; Díaz-Maroto NG; Sanjuan X; Serrano T; Berenguer A; Moreno V; Gonçalves-Ribeiro S; Salazar R; Villanueva A; Molleví DG
    Mol Cancer Res; 2014 Sep; 12(9):1254-66. PubMed ID: 24829396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.
    Cantini L; Isella C; Petti C; Picco G; Chiola S; Ficarra E; Caselle M; Medico E
    Nat Commun; 2015 Nov; 6():8878. PubMed ID: 27305450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.